1146 feeds
357 categories
594 articles (<24 hours)
28 registered users

Use the Mobile version

Follow our Twitter feed

View our Linkpartners


Register | Retrieve


RSS FeedsCardiovascular Outcomes for People Using Anticoagulation Strategies
(WorldNews Health)


17 november 2019 02:00:04

Cardiovascular Outcomes for People Using Anticoagulation Strategies
(WorldNews Health)

Contribution To Literature: The COMPASS trial showed that rivaroxaban plus aspirin was associated with fewer adverse cardiovascular events, but more major bleeding events vs. aspirin alone. Description: The goal of the trial was to evaluate anticoagulation strategies with rivaroxaban among patients with stable atherosclerosis. Study Design Randomized Parallel Blinded Patients with stable atherosclerosis were randomized to rivaroxaban 2.5 mg twice daily plus aspirin (n = 9,152) vs. rivaroxaban 5 mg twice daily alone (n = 9,117) vs. aspirin alone (n = 9,126). Total number of enrollees: 27,395 Duration of follow-up: mean 23 months Mean patient age: 68 years Percentage female: 23% Percentage...

53 viewsCategory: Science > Medicine
Eagle`s Eye View: Day 1 Highlights | AHA 2019
(WorldNews Health)
Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina
(WorldNews Health)
blog comments powered by Disqus

Copyright © 2008 - 2022 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten